Evidence map›Paper›PMID 40740947›Full record

ArticleFrontiers in medicine2025

Validation of "Clinical Red Flags" for RA-ILD in an Italian cohort.

Eneida Cela, Chiara Bonini, Francesco Cavalli, Alessandra Luciano, Barbara Kroegler, Josuel Ora, Alberto Bergamini, Marcello Chiocchi, Paola Rogliani, Maria Sole Chimenti and 1 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eneida CelaRheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", Rome, Italy.
Chiara BoniniRheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", Rome, Italy.
Francesco CavalliDivision of Respiratory Medicine, University Hospital Policlinico Tor Vergata, Rome, Italy.
Alessandra LucianoDepartment of Diagnostic Imaging and Interventional Radiology, University of Rome Tor Vergata, Rome, Italy.
Barbara KroeglerRheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", Rome, Italy.
Josuel OraDivision of Respiratory Medicine, University Hospital Policlinico Tor Vergata, Rome, Italy.
Alberto BergaminiRheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", Rome, Italy.
Marcello ChiocchiDepartment of Diagnostic Imaging and Interventional Radiology, University of Rome Tor Vergata, Rome, Italy.
Paola RoglianiDivision of Respiratory Medicine, University Hospital Policlinico Tor Vergata, Rome, Italy.
Maria Sole Chimenti *Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", Rome, Italy.
Paola Conigliaro *Rheumatology, Allergology and Clinical Immunology, Department of System Medicine, University of Rome "Tor Vergata", Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Rheumatoid arthritis (RA) is a systemic inflammatory disease, characterized by articular and extra-articular manifestations, including Interstitial Lung Disease (ILD). An early diagnosis of ILD can be essential in improving disease outcome. A clinical practice checklist has previously been proposed, highlighting red flags in signs and symptoms suggestive of RA-ILD. Our aim was to validate the "checklists of red flags signs or symptoms suggestive of RA-ILD" in our cohort of RA patients, by assessing the diagnostic utility of dyspnea, cough, and crackles, both individually and in combination. Methods: We performed a retrospective study including medical charts of consecutive RA patients fulfilling 2010 ACR/EULAR classification criteria. The diagnosis of RA-ILD was based on the chest HRCT exam. The primary symptoms and signs of ILD, namely cough, crackles, and dyspnea, were considered separately and in combination to determine diagnostic performance metrics. Results: Our cohort included 107 patients with RA, from which 55 (51.4%) with a diagnosis of RA-ILD. Female patients were predominant in both RA-ILD and No-ILD groups (56.4 and 82.6% respectively), with a significantly higher proportion in the latter ( Conclusion: Overall, crackles and dyspnea were the most significant markers of RA-ILD, both individually, and in combination. This study confirms that the red flags previously identified, especially in combination, show an important accuracy and reliability as clinical biomarkers in the early detection of RA-ILD.

Indexed as

coughcracklesdyspneainterstitial lung diseaserheumatoid arthritis

Identifiers

PMID40740947
PMCPMC12307416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.